Results 161 to 170 of about 1,686,776 (208)

Postpartum anemia and maternal wellbeing: A cohort analysis of the WOMAN‐2 trial

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 117-126, October 2026.
Abstract Objective We examined the association between postpartum anemia and maternal wellbeing in women who gave birth with anemia. Methods We conducted a cohort analysis using secondary data from the WOMAN‐2 trial. Between August 2019 and September 2023, women with moderate or severe anemia who were giving birth vaginally were recruited from ...
The WOMAN‐2 Trial Collaborators   +180 more
wiley   +1 more source

Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress. [PDF]

open access: yesBioDrugs
Gjølberg TT   +5 more
europepmc   +1 more source

Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis. [PDF]

open access: yesPathol Int, 2021
Nabeshima Y   +9 more
europepmc   +1 more source

Genetic and Pharmacologic Inhibition of Myostatin Restores Muscle Mass in a Dynamin 2‐Related Centronuclear Myopathy Mouse Model

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 5, October 2026.
ABSTRACT Background Autosomal dominant centronuclear myopathy (ADCNM), most commonly caused by mutations in the dynamin 2 (DNM2) gene, is a rare congenital myopathy characterized by progressive muscle weakness and atrophy. Myostatin, a key negative regulator of skeletal muscle mass, has shown therapeutic potential in several models of neuromuscular ...
Durieux Anne‐Cécile   +20 more
wiley   +1 more source

Harnessing Natural Killer Cells: From Neuroimmunology to Novel Therapies for Central Nervous System Diseases

open access: yesMedComm, Volume 7, Issue 10, October 2026.
This review delineates the multifaceted roles of natural killer (NK) cells in the central nervous system, spanning direct cytolysis, immunoregulation, and crosstalk with the brain microenvironment. We evaluate the translational potential and challenges of NK cell immunotherapies for a spectrum of neurological conditions.
Kaihang Deng, Wai Po Chong
wiley   +1 more source

Research progress on neonatal Fc receptor and its application. [PDF]

open access: yesZhejiang Da Xue Xue Bao Yi Xue Ban, 2021
Hu M, Wei S, Zhou W, Wang P.
europepmc   +1 more source

Myasthenia Gravis and Thymoma

open access: yesMuscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy